logo

Orchard Therapeutics Plc (ORTX)



Trade ORTX now with
  Date
  Headline
3/21/2019 7:16:57 AM Orchard Therapeutics FY Net Loss Attributable To Ordinary Shareholders $230.5 Mln Vs Loss $39.7 Mln Last Year
3/18/2019 7:07:50 AM Orchard Therapeutics Appoints Ran Zheng Chief Technical Officer
3/11/2019 7:16:03 AM Orchard Therapeutics Announces Acceptance Of OTL-200 Abstract For MLD At EBMT
2/6/2019 7:35:22 AM Orchard Therapeutics Announces Acceptance Of Late-Breaking Abstracts Of OTL-101 For ADA-SCID And OTL-102 For X-CGD
12/14/2018 7:31:16 AM Orchard Therapeutics And SIRION Announce Licensing Agreement To Enhance Gene Therapy Manufacturing Efficiency
12/7/2018 7:31:34 AM Orchard Therapeutics Appointms Alicia Secor To Its Board
11/26/2018 6:25:14 AM Wedbush Starts Orchard Therapeutics plc (ORTX) At Outperform With $25 Price Target